Cetera Advisor Networks LLC Care Dx, Inc. Transaction History

Cetera Advisor Networks LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$7.96 - $12.37 $16,938 - $26,323	2,128 Added 4.01%	55,179 $584,000
Q4 2023 Feb 13, 2024	BUY	$4.9 - $12.86 $72,240 - $189,594	14,743 Added 38.49%	53,051 $636,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $2,800 - $4,504	-400 Reduced 1.03%	38,308 $268,000
Q2 2023 Aug 09, 2023	BUY	$7.61 - $9.46 $19,976 - $24,832	2,625 Added 7.27%	38,708 $329,000
Q1 2023 May 15, 2023	BUY	$8.83 - $17.61 $115,284 - $229,916	13,056 Added 56.7%	36,083 $329,000
Q4 2022 Feb 14, 2023	BUY	$10.88 - $20.05 $84,037 - $154,866	7,724 Added 50.47%	23,027 $262,000
Q3 2022 Nov 10, 2022	BUY	$16.06 - $26.39 $245,766 - $403,846	15,303 New	15,303 $260,000
Q2 2022 Aug 11, 2022	SELL	$20.49 - $39.72 $153,879 - $298,297	-7,510 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$28.19 - $46.6 $80,341 - $132,810	2,850 Added 61.16%	7,510 $278,000
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $43,260 - $77,280	1,050 Added 29.09%	4,660 $212,000
Q3 2021 Nov 16, 2021	BUY	$59.15 - $91.99 $17,745 - $27,597	300 Added 9.06%	3,610 $229,000
Q2 2021 Aug 13, 2021	BUY	$63.02 - $95.11 $208,596 - $314,814	3,310 New	3,310 $303,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.